AMGN compared with CRIS: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

CRISCuris Inc

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

CRISCuris Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

AMGNAmgen Inc

478.34· pre 479.89· delayed

Mkt cap$258.8BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

CRISCuris Inc

1.11· pre 0.95· delayed

Pre-marketNov 5 '26delayed

Mkt cap$1.5MRevenue$1MQ4 FY25Revenue$9MFY25

Compare

Pre-marketNov 5 '26delayed

AMGNAmgen Inc

CRISCuris Inc

478.34pre 479.89delayed

Price

1.11pre 0.95delayed

$258.8B

Mkt cap

$1.5M

Q3 FY26$10.4B

Revenue

$1MQ4 FY25

FY25$36.8B

Revenue

$9MFY25

AMGN478.34vsCRIS1.11Pre-marketNov 5 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

CRIS: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Shared 0

No shared counterparties.

Only CRIS 1

—Genentechunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

AMGN, solidCRIS, dashed